Comparison of the Effectiveness and Tolerability of Exenatide Once-weekly Compared to Basal Insulins

CompletedOBSERVATIONAL
Enrollment

7,000

Participants

Timeline

Start Date

October 28, 2014

Primary Completion Date

October 28, 2014

Study Completion Date

October 28, 2014

Conditions
Type 2 Diabetes
Interventions
DRUG

exenatide once weekly

exenatide treatment in the customary clinical care in the USA

DRUG

basal insulin

basal insulin treatment in the customary clinical care in USA

Trial Locations (1)

02215

Optum Epidemiology, Boston

Sponsors

Lead Sponsor

All Listed Sponsors
lead

AstraZeneca

INDUSTRY